ISB News

ISB President Dr. Jim Heath

ISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and Immunotherapies

The NCI awarded ISB a 5-year, $13 million grant to lead a comprehensive cancer center and study sequential combinations of targeted inhibitors and immunotherapies. The program is designed to determine if the treatments yield greater patient benefit when administered in sequence rather than as monotherapies or as simultaneously administered combinations.

2022 ISB Virtual Microbiome Series

2022 ISB Virtual Microbiome Series Announced

Our multi-day microbiome-themed virtual course and symposium is back for the third year! ISB is hosting a two-day course on October 12 & 13, 2022, followed by a symposium on October 14, 2022 on global perspectives in microbiome research. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious people from across the globe.

Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

ISB Assistant Professor Dr. Sean Gibbons talked about the science behind statins in our most recent Research Roundtable virtual presentation. His talk was titled “Bugs vs. Drugs: How Our Unique Gut Microbiomes Shape Our Personalized Responses to Statins.”

Drs. Serdar Turkarslan and Christian Diener

ISB Honors Researchers Who Give Back to STEM Education

This year, two deserving scientists were bestowed recognition for giving back to STEM education. Dr. Serdar Turkarslan is the recipient of the JoAnn Chrisman Award for Distinguished Service to STEM Education, and Dr. Christian Diener was awarded the Dr. Christine Schaeffer Award for Exemplary Service to STEM Education. 

Spotlight on ISB Education graphic

2021-22 School Year ISB Education Highlights

From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.

Innovator Award Program ROI

Six Years In, ISB’s Innovator Award Program an ‘Unqualified Success’ 

The fifth cycle of ISB’s Innovator Award Program officially wrapped up this week with the principal investigators of the 2021-22 projects delivering their final presentations. In April, three 2022-23 Innovator Award collaborative projects were announced. The Innovator Award Program was launched in 2017, and has been tremendously successful.  

Bringing DNA Sequencing to the High School Classroom

Christopher Lausted and Dr. Danielle Vermaak were featured guests of an ISB Research Roundtable presentation. The husband-and-wife team detailed the planning and rollout of a DNA sequencing curriculum project that was tested in Vermaak’s Lincoln High School science classroom in Seattle.

Gut Microbiome Composition Predictive of Patient Response to Statins

New ISB research shows that different patient responses to statins can be explained by the variation in the human microbiome. The findings were published in the journal Med, and suggest that microbiome monitoring could be used to help optimize personalized statin treatments.

Risk Factors for Severe COVID-19 in Hospitalized Adults Differ by Age

A just-published study provides new information about which hospitalized COVID-19 patients are most likely to need mechanical ventilation or to die. The ISB-led work shows that vital signs and lab results at the time of hospital admission are the most accurate predictors of disease severity, more so than comorbidities and demographics.

Dr. Sui Huang on the Science Behind Masks

On April 7, 2022, Dr. Sui Huang spoke at a Research Roundtable event on the topic of “The Science Behind Masks.” In light of the recent changes to masking mandates, Dr. Huang explained the science behind how masks work and gave the tools to make an informed decision for yourself.

Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest

As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.

2022 Innovator Awards

Three Collaborative Projects Announced for ISB’s 2022 Innovator Award Program

ISB kicked off the sixth year of our successful Innovator Award Program by announcing three collaborative projects. This internal program is designed to support novel research ideas that cut across disciplines and research groups. Washington Research Foundation once again generously pledged $100,000 to fund the awards.

Jim Heath AACR Academy Fellow

Dr. Jim Heath Named Fellow of AACR Academy Class of 2022

Dr. Jim Heath was announced as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022. “I am honored and humbled to be recognized as part of this renowned group of researchers who have done so much to move our understanding of cancer forward,” Heath said.

careers Ukraine

Institute for Systems Biology Expresses our Solidarity with Ukraine

A message to Ukrainian scientists Institute for Systems Biology expresses our solidarity with Ukraine. We are saddened by the invasion of Ukraine, and our thoughts are with those in affected regions. We highly encourage Ukrainian scientists to consider career opportunities in research at ISB, and we will give careful consideration to any who apply. It is our hope that peace is reclaimed in Ukraine and that a healthy, prosperous, sustainable…

New York Times’ Matt Richtel on the ‘Elegant’ Immune System

In the first ISB-Town Hall Seattle Science Series of 2022, ISB President Dr. Jim Heath sat down with New York Times Pulitzer Prize winning reporter and bestselling author Matt Richtel for a wide ranging discussion that touched on the incredible immune system, distracted driving, social isolation, and much more.

ISB Research on Long COVID featured on PBS NewsHour

Who is most likely to suffer from long COVID? In this PBS NewsHour segment, William Brangham interviews Swedish’s Dr. Jason Goldman, an author and collaborator on the ISB-led study on long COVID published in the journal Cell.

WSJ Long COVID Thumbnail

ISB Research on Long COVID featured in the Wall Street Journal

In an article published by Sumathi Reddy for the Wall Street Journal titled, “The New Clues About Who Will Develop Long Covid ,” findings of an ISB-led study published in the journal Cell are covered, along with two complementary Long Covid studies conducted by other research organizations.

John Gillotte

ISB Research On Long COVID Featured in the New York Times

In an article published by Pam Belluck for the New York Times titled, “New Research Hints at 4 Factors That May Increase Chances of Long Covid,” findings of an ISB-led study published in the journal Cell are covered in depth, including quotes from ISB president Dr. Jim Heath.